ClinVar Genomic variation as it relates to human health
NM_201253.3(CRB1):c.3307G>A (p.Gly1103Arg)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_201253.3(CRB1):c.3307G>A (p.Gly1103Arg)
Variation ID: 5739 Accession: VCV000005739.23
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 1q31.3 1: 197435170 (GRCh38) [ NCBI UCSC ] 1: 197404300 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 20, 2014 Sep 16, 2024 Apr 9, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_201253.3:c.3307G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_957705.1:p.Gly1103Arg missense NM_001193640.2:c.2971G>A NP_001180569.1:p.Gly991Arg missense NM_001257965.2:c.3235G>A NP_001244894.1:p.Gly1079Arg missense NM_001257966.2:c.2129-430G>A intron variant NR_047563.2:n.3260G>A non-coding transcript variant NR_047564.2:n.3468G>A non-coding transcript variant NC_000001.11:g.197435170G>A NC_000001.10:g.197404300G>A NG_008483.2:g.238709G>A P82279:p.Gly1103Arg - Protein change
- G1103R, G1079R, G991R
- Other names
- -
- Canonical SPDI
- NC_000001.11:197435169:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Exome Aggregation Consortium (ExAC) 0.00002
The Genome Aggregation Database (gnomAD) 0.00003
The Genome Aggregation Database (gnomAD), exomes 0.00003
Trans-Omics for Precision Medicine (TOPMed) 0.00003
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
CRB1 | - | - |
GRCh38 GRCh37 |
1944 | 1969 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Feb 15, 2024 | RCV000006093.10 | |
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Mar 14, 2024 | RCV000006094.8 | |
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Apr 9, 2024 | RCV000086341.7 | |
Pathogenic (2) |
criteria provided, single submitter
|
Jan 2, 2024 | RCV000648818.10 | |
Early-onset retinal dystrophy
|
Pathogenic (1) |
no assertion criteria provided
|
Dec 13, 2017 | RCV000786009.1 |
Pathogenic (2) |
no assertion criteria provided
|
Sep 16, 2020 | RCV001002998.2 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jan 22, 2019 | RCV001073404.2 | |
Pathogenic (1) |
criteria provided, single submitter
|
Apr 11, 2023 | RCV003450617.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jan 22, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Retinal dystrophy
Affected status: yes
Allele origin:
germline
|
Blueprint Genetics
Accession: SCV001238945.1
First in ClinVar: Apr 18, 2020 Last updated: Apr 18, 2020
Comment:
My Retina Tracker patient
|
|
|
Pathogenic
(Mar 14, 2024)
|
criteria provided, single submitter
Method: research
|
Retinitis pigmentosa 12
Affected status: unknown
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV004801139.2
First in ClinVar: Mar 16, 2024 Last updated: Apr 06, 2024 |
|
|
Pathogenic
(Apr 09, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000321519.6
First in ClinVar: Oct 09, 2016 Last updated: Sep 16, 2024 |
Comment:
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16543197, … (more)
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16543197, 20956273, 22065545, 23449718, 26147992, 25133751, 17964524, 17724218, 19140180, 15024725, 31054281, 31456290, 31589614, 33441055, 35119454, 34884448, 33921607) (less)
|
|
Pathogenic
(Apr 01, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000339784.4
First in ClinVar: Dec 06, 2016 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 1
Sex: mixed
|
|
Pathogenic
(Apr 11, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Retinitis pigmentosa 12
Affected status: no
Allele origin:
germline
|
Genome-Nilou Lab
Accession: SCV004180146.1
First in ClinVar: Dec 24, 2023 Last updated: Dec 24, 2023 |
|
|
Pathogenic
(Apr 11, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Leber congenital amaurosis 8
Affected status: no
Allele origin:
germline
|
Genome-Nilou Lab
Accession: SCV004180144.1
First in ClinVar: Dec 24, 2023 Last updated: Dec 24, 2023 |
|
|
Pathogenic
(Apr 11, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Pigmented paravenous retinochoroidal atrophy
Affected status: no
Allele origin:
germline
|
Genome-Nilou Lab
Accession: SCV004180145.1
First in ClinVar: Dec 24, 2023 Last updated: Dec 24, 2023 |
|
|
Pathogenic
(Jan 02, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Leber congenital amaurosis 8
Retinitis pigmentosa 12
Explanation for multiple conditions: Uncertain.
The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases.
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000770639.7
First in ClinVar: May 28, 2018 Last updated: Feb 28, 2024 |
Comment:
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1103 of the CRB1 protein (p.Gly1103Arg). … (more)
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1103 of the CRB1 protein (p.Gly1103Arg). This variant is present in population databases (rs62636275, gnomAD 0.005%). This missense change has been observed in individuals with Leber congenital amaurosis or retinitis pigmentosa (PMID: 16543197, 19140180, 23449718). It is commonly reported in individuals of Israeli and Palestinian ancestry (PMID: 23449718). ClinVar contains an entry for this variant (Variation ID: 5739). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CRB1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Feb 15, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Leber congenital amaurosis 8
Affected status: unknown
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV004211137.2
First in ClinVar: Dec 30, 2023 Last updated: Jun 17, 2024 |
|
|
Pathogenic
(Feb 15, 2009)
|
no assertion criteria provided
Method: literature only
|
LEBER CONGENITAL AMAUROSIS 8
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000026275.3
First in ClinVar: Apr 04, 2013 Last updated: Apr 10, 2015 |
Comment on evidence:
In all 4 affected members of a family of Middle Eastern origin segregating autosomal recessive Leber congenital amaurosis-8 (LCA8; 613835) and high to extreme hyperopia, … (more)
In all 4 affected members of a family of Middle Eastern origin segregating autosomal recessive Leber congenital amaurosis-8 (LCA8; 613835) and high to extreme hyperopia, Abouzeid et al. (2006) identified homozygosity for a 3307G-A transition in exon 9 of the CRB1 gene, resulting in a gly1103-to-arg (G1103R) substitution at a highly conserved site in the protein. The mutation was found in heterozygous state in 4 unaffected family members and was not found in 104 healthy Caucasian volunteers. Abouzeid et al. (2006) showed that hyperopia and LCA were linked to the mutant CRB1 gene itself and were not dependent on unlinked modifiers. Abouzeid et al. (2006) noted that the G1103R mutation had previously been identified in compound heterozygous state in a patient with sporadic LCA by Hanein et al. (2004). In affected members of a consanguineous family with early-onset retinitis pigmentosa (RP12; 600105), Benayoun et al. (2009) identified compound heterozygosity for the G1103R mutation and a 10-bp deletion (604210.0012) in the CRB1 gene. (less)
|
|
Pathogenic
(Feb 15, 2009)
|
no assertion criteria provided
Method: literature only
|
RETINITIS PIGMENTOSA 12
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000026276.3
First in ClinVar: Apr 04, 2013 Last updated: Apr 10, 2015 |
Comment on evidence:
In all 4 affected members of a family of Middle Eastern origin segregating autosomal recessive Leber congenital amaurosis-8 (LCA8; 613835) and high to extreme hyperopia, … (more)
In all 4 affected members of a family of Middle Eastern origin segregating autosomal recessive Leber congenital amaurosis-8 (LCA8; 613835) and high to extreme hyperopia, Abouzeid et al. (2006) identified homozygosity for a 3307G-A transition in exon 9 of the CRB1 gene, resulting in a gly1103-to-arg (G1103R) substitution at a highly conserved site in the protein. The mutation was found in heterozygous state in 4 unaffected family members and was not found in 104 healthy Caucasian volunteers. Abouzeid et al. (2006) showed that hyperopia and LCA were linked to the mutant CRB1 gene itself and were not dependent on unlinked modifiers. Abouzeid et al. (2006) noted that the G1103R mutation had previously been identified in compound heterozygous state in a patient with sporadic LCA by Hanein et al. (2004). In affected members of a consanguineous family with early-onset retinitis pigmentosa (RP12; 600105), Benayoun et al. (2009) identified compound heterozygosity for the G1103R mutation and a 10-bp deletion (604210.0012) in the CRB1 gene. (less)
|
|
Pathogenic
(Dec 13, 2017)
|
no assertion criteria provided
Method: research
|
Early-onset retinal dystrophy
Affected status: yes
Allele origin:
inherited
|
Molecular Genetics Laboratory, Institute for Ophthalmic Research
Accession: SCV000924649.1
First in ClinVar: Jun 28, 2019 Last updated: Jun 28, 2019 |
|
|
Pathogenic
(Jun 23, 2019)
|
no assertion criteria provided
Method: research
|
leber congenital amaurosis
Affected status: yes
Allele origin:
inherited
|
Sharon lab, Hadassah-Hebrew University Medical Center
Accession: SCV001161052.1
First in ClinVar: Feb 16, 2020 Last updated: Feb 16, 2020 |
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: research
|
Leber congenital amaurosis 8
Affected status: yes
Allele origin:
inherited
|
Laboratory of Genetics in Ophthalmology, Institut Imagine
Accession: SCV001425486.1
First in ClinVar: Aug 01, 2020 Last updated: Aug 01, 2020 |
Number of individuals with the variant: 2
|
|
Pathogenic
(Sep 16, 2020)
|
no assertion criteria provided
Method: clinical testing
|
Leber congenital amaurosis
Affected status: unknown
Allele origin:
germline
|
Natera, Inc.
Accession: SCV001460950.1
First in ClinVar: Jan 02, 2021 Last updated: Jan 02, 2021 |
|
|
not provided
(-)
|
no classification provided
Method: not provided
|
not provided
Affected status: not provided
Allele origin:
not provided
|
Retina International
Accession: SCV000118487.1
First in ClinVar: Feb 20, 2014 Last updated: Feb 20, 2014
Comment:
http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg19&id=RISN_CRB1:c.3307G>A
|
|
|
not provided
(-)
|
no classification provided
Method: phenotyping only
|
Leber congenital amaurosis 8
Retinitis pigmentosa 12
Explanation for multiple conditions: Uncertain.
The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases.
Affected status: unknown
Allele origin:
germline,
unknown
|
GenomeConnect - Invitae Patient Insights Network
Accession: SCV001749793.2
First in ClinVar: Jul 18, 2021 Last updated: Jun 17, 2024 |
Comment:
Variant reported in multiple Invitae PIN participants. Variant interpreted as Pathogenic and reported most recently on 11-23-2020 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are … (more)
Variant reported in multiple Invitae PIN participants. Variant interpreted as Pathogenic and reported most recently on 11-23-2020 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. (less)
Observation 1:
Number of individuals with the variant: 1
Clinical Features:
Abnormal retinal morphology (present)
Age: 10-19 years
Sex: female
Testing laboratory: Invitae
Date variant was reported to submitter: 2020-03-20
Testing laboratory interpretation: Pathogenic
Observation 2:
Number of individuals with the variant: 1
Clinical Features:
Abnormal retinal morphology (present)
Indication for testing: Diagnostic
Age: 0-9 years
Sex: male
Testing laboratory: Invitae
Date variant was reported to submitter: 2020-11-23
Testing laboratory interpretation: Pathogenic
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Homozygosity Mapping in Leber Congenital Amaurosis and Autosomal Recessive Retinitis Pigmentosa in South Indian Families. | Srilekha S | PloS one | 2015 | PMID: 26147992 |
Mutation screening of retinal dystrophy patients by targeted capture from tagged pooled DNAs and next generation sequencing. | Watson CM | PloS one | 2014 | PMID: 25133751 |
Mutations in CRB1 are a relatively common cause of autosomal recessive early-onset retinal degeneration in the Israeli and Palestinian populations. | Beryozkin A | Investigative ophthalmology & visual science | 2013 | PMID: 23449718 |
CRB1 mutations in inherited retinal dystrophies. | Bujakowska K | Human mutation | 2012 | PMID: 22065545 |
Genetic heterogeneity in two consanguineous families segregating early onset retinal degeneration: the pitfalls of homozygosity mapping. | Benayoun L | American journal of medical genetics. Part A | 2009 | PMID: 19140180 |
Leber congenital amaurosis - a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture. | Stone EM | American journal of ophthalmology | 2007 | PMID: 17964524 |
Clinical and molecular genetics of Leber's congenital amaurosis: a multicenter study of Italian patients. | Simonelli F | Investigative ophthalmology & visual science | 2007 | PMID: 17724218 |
A G1103R mutation in CRB1 is co-inherited with high hyperopia and Leber congenital amaurosis. | Abouzeid H | Ophthalmic genetics | 2006 | PMID: 16543197 |
Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis. | Hanein S | Human mutation | 2004 | PMID: 15024725 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CRB1 | - | - | - | - |
Text-mined citations for rs62636275 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.